Malignancy-Associated Hemophagocytic Lymphohistiocytosis: Clinical Characteristics, Treatment Patterns, and Survival Outcomes in a Tertiary Care Center Cohort.
Identifying features of cancer-linked immune flare-ups highlights diagnostic delays and the need for rapid multi-specialty response.
Single-center cohort characterizes clinical features, treatment patterns, and poor survival outcomes in malignancy-associated HLH, highlighting diagnostic delays and need for rapid multidisciplinary management. This record was retained from the prior triage attempt for PubMed pipeline handoff.
What the study was
- Study design
- retrospective cohort (tertiary care center)
- Category
- hematologic_malignancies
- Maturity
- Validated
- Journal
- Clin Lymphoma Myeloma Leuk
Why it surfaced
Single-center cohort providing real-world data on malignancy-associated HLH management and outcomes, relevant to this rare and frequently fatal hematologic emergency.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.